BioCorRx Inc. entered into a subscription agreement for the private placement of 174,409 common shares at an issue price of $1.72 per share for gross proceeds of $299,983.480 along with a warrant on April 4, 2023. The transaction included participation from an accredited investor. The warrant is exercisable for three years from the date of issuance at an exercise price of $4 per share to purchase up to 174,409 common shares.

The securities have been issued pursuant to exemption provided under Regulation D.